Philip Gardiner
- AZD3199: A fast acting β2-receptor agonist with a long duration of actionBy Alan Young, Roger Bonnert, Elaine Cadogan, Stephen Connolly, Philip Gardiner, Stephen Jordan, David Nicholls, Stuart Paine, Gary Pairaudeau and Michael StocksAlan YoungResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomRoger BonnertResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomElaine CadoganResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomStephen ConnollyResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomPhilip GardinerResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomStephen JordanResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomDavid NichollsResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomStuart PaineResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomGary PairaudeauResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomMichael StocksResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United Kingdom
- AZD3199: A potent and selective β2-adrenergic receptor agonist with rapid onset of actionBy Alan Young, Rupert Austin, Roger Bonnert, Elaine Cadogan, Stephen Connolly, Philip Gardiner, Stephen Jordan, Mandy Lawson, Peter Mutch, David Nicholls, Stuart Paine, Gary Pairaudeau and Michael StocksAlan YoungResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomRupert AustinResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomRoger BonnertResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomElaine CadoganResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomStephen ConnollyResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomPhilip GardinerResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomStephen JordanResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomMandy LawsonResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomPeter MutchResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomDavid NichollsResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomStuart PaineResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomGary PairaudeauResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United KingdomMichael StocksResearch and Development, AstraZeneca R&D Charnwood, Loughborough, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.